It was found by Hitchings, Elion, VanderWerff, and Falco (1948) that many 2: 4-diaminopyrimidines are powerful antagonists of pteroylglutamic acid in cultures of Lactobacillus casei (cf. Hitchings, Elion, Falco, Russell, Sherwood, and VanderWerff, 1950) . The formal analogy between 2: 4-diamino-5-p-chlorophenoxypyrimidine (I) and proguanil (" Paludrine ") (II), and the finding that proguanil was also an antagonist of pteroylglutamic acid, suggested that the pyrimidine compound might have antimalarial activity (Falco, Hitchings, Russell, and VanderWerff, 1949) . 
This was shown to be the case, and a short report of the antimalarial activity of another member of this group of compounds was published later by Goodwin (1949) A large number of derivatives of 2: 4-diaminopyrimidine substituted in the 5-and 6-positions has now been prepared and tested against laboratory plasmodial infections. The results obtained upon 158 of these substances are recorded in the present paper.
A dose was considered to be "active " when the mean percentage parasitaemia of the treated group of animals was lowered to 1 per cent or less of the mean percentage parasitaemia of untreated controls.
Active compounds were assayed by the method described by Marshall (1945) . The mean percentage parasitaemia in each group of chicks was plotted against the logarithm of the dose, and a curve for each compound was drawn. A curve was determined for a standard antimalarial drug in the same experiment, and the relative activity of the compounds estimated from the ratio of the doses which effected a 50 per cent reduction in parasitaemia compared with untreated controls. Sporozoite infections were induced by the method of Davey (1946b) . Five-day-old chicks were inoculated intravenously with 0.2-ml. quantities of a suspension of sporozoites in a mixture of equal parts of 0.5 per cent glucose-saline and heparinized chick-blood. The suspension was prepared by grinding in a mortar the requisite number of lightly anaesthetized infected A des aegypti mosquitoes with a little of the saline-blood medium. The suspension was lightly centrifuged and the supernatant sporozoite suspension diluted with medium so that 0.2 ml. contained the equivalent of one mosquito. In untreated controls this inoculum usually caused death from blockage of the brain capillaries with exoerythrocytic schizonts in 9-10 days. Drug treatment was similar to that used for blood infections.
P. berghei infections.-The mice used for the test weighed from 20 to 30 grammes. The strain of plasmodium was that described by Vincke and Lips (1948) , and was obtained through the kindness of Professor H. E. Shortt. The method used was similar to that described by Goodwin (1949) , the mice being infected by intraperitoneal injection of approximately 5 x 10' parasitized red cells suspended in glucose-saline. The first dose of drug was given by mouth 2-3 hours after inoculation and further doses were given twice daily for 3 days. Blood films were made on the seventh day.
Attempts were made to cultivate Anopheles concolor, the vector of this parasite (Vincke and Leleup, 1949) . Eggs and larvae were kindly sent from the Belgian Congo by Drs. Vincke and Hanse, but we were unable to obtain the correct conditions for their development. For this reason, no results can as yet be recorded for the effect of the new compounds upon sporozoite-induced infections with P. berghei. Tissue-forms of the parasite have been described by Van den Berghe, Vincke, and Chardome (1950) in the histiocytes of the liver and the endothelial cells of the brain capillaries 36 hours after inoculation of infected blood, but we have not yet satisfied ourselves that the exoerythrocytic forms occur in mice after blood inoculation. The results are presented in Tables I-IX . The activity of each compound is recorded as a " score " from 0 to 5 according to the key on p. 186, and the proguanil equivalents of the more potent substances are also recorded in parentheses. Activity against blood-induced infections of P. gallinaceum and P. berghei
With a large series of substances such as this, which are closely related chemically and many of which have similar solubilities, it is profitable to consider the effect of structure upon therapeutic potency.
The effect of the 5-substituent.-Although some antimalarial activity is shown by substances with simple substituents in the 5-position of the pyrimidine nucleus (Table III, 48-211, 49-251; Table IV , 48-29) the really potent substances are found among those with substituents containing a benzene nucleus. Of these, the phenyl series (Table I) is generally more active than the benzyl series (Table II) , which in turn is more active than the phenoxy series (Table III) .
An electron-attracting group, such as nitro-or halogen in the para-position of the benzene ring enhances activity; ortho-and meta-derivatives are generally less active than the corresponding para-compounds (Table I, Table II, , although in the phenoxy series the m-chloro-compounds are about equal in activity to the p-chloro compounds against P. gallinaceum (Table  III, 48-287, 48-122, 49-265, and 48-210) . Corresponding. chloro-, bromo-, and fluoro-compounds are all of about the same degree of activity when assessed by the Dichloro-derivatives in the phenyl series (Table I, 50-99, 50-11, 50-197, 50-276, 50-280, 50-292) are also very potent antimalarials especially against P. berghei, and have activities approximately equal to the corresponding p-chloro-compounds. The 3': 4'-dichlorophenyl-6-methyl compound , although about equal in activity to the corresponding 4'-chlorophenyl compound (50-58) against P. gallinaceum, is actually three times as active against P. berghei. The 3': 4'-dichlorophenyl-6-ethyl compound (50-276) has one-third of the activity of the corresponding 4'-chlorophenyl compound (50-63) against P. gallinaceum, but the two substances are equally active against P. berghei. Phenoxy derivatives with more than one halogen substituent, on the other hand, are almost without action (Table III, 48-152, 49-19, 49-225) . Toxicity tests show that the 3': 4'-dichlorophenyl compounds are rather more toxic than the monochloro-, and delayed deaths are found to occur among the mice for 5 days after oral administration of the drug (Table VI) . A similar prolonged toxic action was observed with the p-chlorophenyl compound with no 6-substituent (Table I, .
The failure of a second chlorine atom in the benzene ring to enhance activity against P. gallinaceum in the 2: 4-diaminopyrimidines is interesting in view of the recent publication of Curd, Davey, Hendry, and Rose (1950) , in which the dichloroderivative corresponding to proguanil is shown to be 2.5 to 5 times as active as proguanil. It is also more toxic to some species of animals. We find this compound in preliminary tests to be 1 to 3 times as active as proguanil against P. berghei.
The nitro-compounds of the phenyl series are less active than the corresponding chloro-compounds; in the phenoxy and benzyl series the nitro-derivatives are somewhat more active than the chloro-, especially when P. gallinaceum is used as the test-organism.
Electron-donating substituents such as alkyl and methoxy groups do not increase antimalarial activity (Table 1 , 50-101, 50-100).
Alkoxy compounds above methoxy (Table III, 48-211, 49-251, 50-174) have roughly the order of activity of the unsubstituted phenoxy derivatives. However, by appropriate substitutions the activity of the latter may be greatly enhanced, whereas the alkoxy series is not subject to similar modification.
The effect of the 6-substituent.-The antimalarial activity of the p-chloro derivatives is enhanced by the introduction of a methyl group in the 6-position of the pyrimidine nucleus. The same generalization probably applies to compounds with other electron-attractive substituents in the benzene nucleus, but does not apply to the dimethylphenoxy or naphthoxy derivatives (Table III, 49-269, 49-318, 48-256, 49-142) . When a series of alkyl derivatives was compared the methyl derivative was found to be the most active in both the benzyl (Table II, 49-224, 50-203, 49-336) and phenoxy series (Table III, 48-210, 50-193, 50-78) . The effect of the nature and length of the alkyl radical was studied in considerable detail in the phenyl series, in which the peak of activity is reached with the 6-ethyl compound, 50-63 (Table I) , which is 60 times as active as proguanil against P. gallinaceum, and 200 times as active against P. berghei. Higher and lower members of the series are less active, but to a different degree with the two species of plasmodium. P. berghei is rather less sensitive than P. gallinaceum to the higher members of the series, but these differences may perhaps be explained by differences in the rates of absorption, metabolism, and excretion of the drugs by the mammalian and avian hosts. In this series it is also noteworthy that the isobutyl is more active than the n-butyl derivative, and that there is a tendency for compounds with an odd number of C-atoms in the chain to be more active than compounds with an even number of C-atoms. The relative activities of this group of compounds (Table I, P. galliraceum. The effects of substituents of other types in the 6-position do not lend themselves to ready interpretation. The 6-phenyl derivatives are less active than their alkyl congeners (Table I, 50-115; Table II, 48-251; Table III , 49-233) . A 3-pyridyl derivative (Table I, has approximately the activity of the phenyl, but the 4-pyridyl is much less active- (Table I , 50-339). In the benzyl series the 6-amino derivatives are only slightly less active than the compounds unsubstituted in position 6, but the 6-chloro-compound is essentially inactive (Table 11, .
Quaternization of a pyrimidine-N atom greatly decreases antimalarial activity (Table IV, .
The relationship of the 2: 4-diaminopyrimidines to similar compounds differing by substitution of the amino groups is worthy of consideration. A large series of pyrimidine derivatives with alkylaminoalkylamino side chains was studied by Davey (1946a) and Curd, Richardson, and Rose (1946) . On the basis of their results and those reported in the present paper, at least two types of pyrimidine antimalarials appear to be distinguishable. The first type is exemplified by those pyrimidines carrying phenyl, phenoxy, or benzyl groupings in the 5-position, and in which substitution of the 2-and/or 4-amino groups appears to diminish the antimalarial activity. For example, 2-p-chloroanilino-4-p-diethylaminoethylaminopyrimidine (Curd, Richardson, and Rose, 1946 ) is less active than 2-amino-4-3-diethylaminoethylaminopyrimidine (Hull, Lovell, Openshaw, and Todd, 1947) , which in turn is less active than 2: 4-diamino-5-phenoxypyrimidine (Table III, . A similar stepwise effect does not appear to be true of the derivatives of 5-benzyl-6-methylpyrimidine, but it is abundantly clear that the unsubstituted 2: 4-diamino-5-benzyl-6-methylpyrimidine (Table II, is much more active than the corresponding compounds with substituted amino groups (Hull, Lovell, Openshaw, Payman, and Todd, 1946; Curd, Richardson, and Rose, 1946) and that the 2: 4-diamino-5- (Curd, Richardson, and Rose, 1946) . Similarly a 2-amino-4-methylamino-5-p-chlorophenoxypyrimidine (Table V, is less active than the corresponding 2: 4-diamino derivative (Table III, .
The second type comprises pyrimidines which are unsubstituted, or carry only alkylsubstituents in the 5-position (those which eventually led to the more active acyclic analogue, proguanil). In this group of compounds, substitution of the amino group is requisite to activity (Basford, Curd, Hoggarth, and Rose, 1947) . This difference between the two groups appears to be borne out by the reported absence of cross-resistance between diaminopyrimidines and proguanil which is discussed below.
The essential nature of the 2-and 4-amino group in the pyrimidine nucleus for activity in the present series receives further confirmation from the lower activity of 2-amino-4-hydroxy (Table V, ) and 2-amino-4-mercapto (Table V, derivatives as compared with the corresponding 2: 4-diaminopyrimidines (Table III, . Furthermore, 4-amino-5-phenyl-and 4-amino-5-pchlorophenylpyrimidines (Table V, 50-27 and 50-28) are only feebly active as compared with the corresponding diamino-derivatives (Table I, . A number of condensed systems containing the 2: 4-diaminopyrimidine structure show moderate though generally unpromising activity (Table V, . In this category the pteridines (Table V, possess activities similar to those of the 2: 4-diamino-pteridines studied by Greenberg (1949) .
Acute oral toxicities in mice of some of the more active compounds from the three main series are shown in Table VI in comparison with those of standard antimalarial drugs. Sporozoite-induced infections of P. gallinaceum and P. cynomolgi The results of treatment of sporozoite-induced infections of P. gallinaceum in chicks with a selection of substances are shown in Tables VII and VIII. It is apparent that the 2: 4-diaminopyrimidines are at least as efficient as proguanil in delaying death from the development of exoerythrocytic schizonts. Greenberg, Trembley, and Coatney (1950) have recently demonstrated that very heavy sporozoite infections such as were used in the experiments recorded in Table VII The effect of three 2 : 4-diaminopyrimidines upon P. cynornolgi infections in monkeys. [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] human malarial infections with pamaquin treatment were most closely paralleled in P. gallinaceum when they used very light infections produced by injecting the equivalent of 0.01 mosquito per chick. We have therefore compared treatment with 2: 4-diaminopyrimidines in heavy and light sporozoite infections, and the results are set forth in Table VIII . It will be seen that with compounds 49-224, 50-58, 50-63, and 50-109, when the chicks are lightly infected, no exoerythrocytic forms could be found, although some of the birds failed to survive to the end of the test. Table IX shows the results of treatment of a small number of rhesus monkeys infected with heavy inocula of sporozoites of P. cynomolgi. It will be seen that, although small doses of the drugs used wete sufficient to suppress the infection, there was little effect upon the tissue forms of the parasite; even 5 mg./kg. given twice daily for six weeks did not prevent or delay the appearance of a heavy relapse of blood infection which occurred a few days after splenectomy.
In spite of the intensive treatment, no ill effects were observed. None of the animals refused food or showed any signs of toxic effects, and the haemoglobin and the red and white cell counts were unaltered. More extensive studies of the toxicity and pharmacology of the 2: 4-diaminopyrimidines will be reported in a further communication.
Action upon other organisms
Many of the compounds, including all the more active antimalarials, were tested against laboratory infections of Trypanosoma rhodesiense, T. congolense, T. cruzi, Leishmania donovani, and Entamoeba histolytica, by the methods described by Burn, Finney, and Goodwin (1950) . No significant activity, apart from slight activity against T. congolense by the phenoxy derivatives, was shown by any. However, many of the 2: 4-diaminopyrimidines have powerful antibacterial activity in vitro. Individual compounds vary in the degree to which they are affected by the presence of blood and serum, and none has very great antibacterial activity in vivo. (Observations of Mr. H. VanderWerff and Mr. S. R. M. Bushby.) It is interesting that the more powerful antimalarials have, in general, the weaker antibacterial action; the best antibacterials are mostly compounds with electron-donating groups in the para-position of the 5-benzene nucleus. An important exception to this generalization is found in the phenyl series (Table I) , in which the most active antimalarial (50-63) has also the highest antibacterial action. In both the phenoxy and benzyl series the compounds with H in the 6-position are more active than 6-alkyl derivatives against bacteria in vitro. Possible use in human malaria It may be valuable to speculate upon the possible uses of these compounds in human malaria. In view of the fact that they show very high activity against three species of Plasmodium in experimental animals, it is likely that they will also be of use against the parasites of man. The effective dose of the 5-p-chlorophenyl-6-ethyl derivative (50-63) is so small that it may well prove an economical compound for suppression, and, because of its relatively low toxicity, a potent drug for the treatment of overt infections. However, as a true causal prophylactic against P. vivax it is less likely to be of value, because large doses fail to affect the exoerythrocytic stages of P. cynomolgi.
Note added in proof: Two of the compounds, 50-63 (Table I ) and 49-224 (Table II) , were further tested against blood-induced P. cathemerium infections of canaries. The minimum effective dose (MED), here defined as the dose which effected a 50 per cent reduction in parasitaemia compared with untreated controls, was estimated graphically as previously described from percentage parasitaemia counts on the sixth day.
The results are summarized in the Table below. The results with P. gallinaceum for 49-224 and 50-63 were estimated from previous assays and are the means of two or more experiments; the results for proguanil in both P. gallinaceum and P. cathemerium infections were taken from the paper by Davey (1946a These results show that two members of the new series, previously shown to be highly active against P. gallinaceum and P. berghei, are considerably less effective against P. cathemerium. However, proguanil shows corresponding variations, yet is active against the plasmodia which infect man, and it may be expected that these two compounds act in a similar way.
